Press Releases for PRGO

Press Releases
The First Israel Fund, Inc. Announces Performance Data and Portfolio Composition
Perrigo Reports Record Sales, Earnings and Cash Flow From Operations for Fiscal 2009
Perrigo Company Announces Quarterly Dividend
Perrigo Company Will Release Fiscal Year 2009 Results on August 18, 2009
Perrigo Announces FDA Approval for Generic Version of NASACORT(R) AQ
Perrigo Receives FDA Approval to Market Cherry and Cinnamon Flavored Nicotine Lozenges
Pomerantz Appointed Co-Lead Counsel in Perrigo Company Securities Class Action
Perrigo Confirms That its Partner Synthon Has Filed for Generic Version of Xyzal(R) Solution and Announcement of Lawsuit by Sepracor/UCB
Perrigo Company to Present At the Deutsche Bank 34th Annual Health Care Conference
Perrigo Company to Present At the Bank of America and Merrill Lynch 2009 Healthcare Conference
Perrigo Reports Record Third Quarter
Perrigo Company Announces Quarterly Dividend
Medimetriks Pharmaceuticals Launches Two New Prescription Brands
Holzer Holzer & Fistel, LLC Announces That It Has Filed a Shareholder Class Action Against Perrigo Company (NASDAQ: PRGO)
WallStSense.Com Issues Free Ratings Report on GLBL, CPST, PRGO and CBST
Perrigo Announces FDA Approval for Sulfacetamide Sodium Topical Suspension USP, 10% (Lotion)
Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Perrigo Company
Perrigo and Partner Cobrek Confirms Filing for Generic Version of Evoclin(R) and Announcement of Lawsuit by Stiefel
Dyer &Amp; Berens LLP Files Class Action Lawsuit on Behalf of Investors Who Purchased or Acquired Perrigo Company Common Stock Between 11/6/08 and 2/2/09; Announces Upcoming Investor Deadline -- PRGO
Dyer & Berens LLP Files Class Action Lawsuit on Behalf of Investors Who Purchased or Acquired Perrigo Company Common Stock Between 11/6/08 and 2/2/09; Announces Upcoming Investor Deadline -- PRGO
Brower Piven Encourages Investors Who Have Losses in Excess of $150,000 From Investment in Perrigo Company to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit Before the May 11, 2009 Lead Plaintiff Deadline
The Brualdi Law Firm, P.C. Announces Class Action Lawsuit Against Perrigo Company
Izard Nobel LLP Announces Class Action Lawsuit Against Perrigo Company
Coughlin Stoia Geller Rudman & Robbins LLP Files Class Action Suit against Perrigo Company
Perrigo Begins Shipments of Ibuprofen PM
Perrigo Reports Record Second Quarter Sales
Perrigo Company Announces Quarterly Dividend - Jan 28 2009 8:50AM
Perrigo Company Appointed Generic Distributor by Medimetriks Pharmaceuticals
Perrigo Company Will Release Second Quarter Fiscal Year 2009 Results on February 3, 2009
Perrigo Company to Present at the 27th Annual JPMorgan Healthcare Conference
Perrigo Announces FDA Final Approval for Ibuprofen PM
Perrigo Settles Desloratadine Patent Litigation
Perrigo Acknowledges Settlement of NASACORT(R) AQ Nasal Spray Patent Litigation
Barr Announces Agreements on Nasacort(R) AQ, Allegra(R) D-12 and Allegra(R) Patent Challenges
Perrigo Acquires Unico Holdings
Perrigo Reports Record First Quarter Sales and Income
Perrigo Company Announces Dividend Increase
Perrigo Announces FDA Tentative Approval for Ibuprofen PM
Perrigo Company Licenses Prescription Brands to Medimetriks Pharmaceuticals
Perrigo Company will Release First Quarter Fiscal Year 2009 Results on November 6, 2008
Perrigo Acquires Mexican Manufacturer Laboratorios Diba, S.A.
Perrigo Company to Present at the JMP Securities 2008 Healthcare Focus Conference
Perrigo Dismissed from Miconazole Patent Litigation
Perrigo Acquires JB Laboratories
Perrigo Company To Present at the Merrill Lynch Global Pharmaceutical Conference
Perrigo Acquires Exclusive Sales and Distribution Rights to Allergy Drug Levocetirizine from Synthon
Perrigo Reports Record Sales, Earnings and Cash Flow from Operations for Fiscal 2008
Perrigo Company Announces Quarterly Dividend - Aug 13 2008 9:36AM
Perrigo Begins Shipments of Famotidine Complete to Customers Nationwide
/C O R R E C T I O N -- Perrigo Company/
Perrigo Company to Present at the Bank of America Specialty Pharmaceuticals Conference
Perrigo Company Will Release Fiscal Year 2008 Results on August 18, 2008
Perrigo Company (PRGO) Chairman and Chief Executive Officer to Ring The NASDAQ Stock Market Opening Bell
Investment Report of China Medical Industry, 2000-2008 Available Now
Perrigo to Grow in Michigan
Perrigo Company Announces Appointment of New Board Member
Perrigo Company to Present at The Oppenheimer & Co. Inc. 8th Annual Consumer Growth Conference
Perrigo Announces Approval for Rx Cetirizine Syrup
Perrigo Confirms Filing for Generic Version of VANOS(R)
Perrigo Company Announces Collaborative Agreement for Generic Topical Products With Pentech - May 27 2008 1:00AM
Perrigo Company to Present at the Citi Investment Research Global Health Care Conference - May 27 2008 12:58AM
BellwetherReport.com Initiates Analyst Coverage on PRGO, CRBC, ESLR and TKLC - May 27 2008 1:17AM
Perrigo Reports Record Sales and Earnings for Third Quarter Fiscal 2008 - Jun 2 2008 2:00AM
Perrigo Receives FDA Approval to Market Orange, Coated Nicotine Gum
Perrigo Company Will Release Third Quarter Fiscal 2008 Results on May 6, 2008
Perrigo Confirms Patent Challenge of Monistat(R) 1 Combination Pack
Perrigo Announces Approval for Over-the-Counter Children's Cetirizine Oral Solution
QED International Associates Announces Changes to the HealthShares(TM) Respiratory Pulmonary Index and the HealthShares(TM) Composite Index